ANDA 200830, held by Watson Labs Inc. Colesevelam Hydrochloride.
As of Nov 15, 2026, ANDA 200830 (Colesevelam Hydrochloride), held by Watson Labs Inc, was first approved by FDA on Sep 2, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 2, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Colesevelam Hydrochloride625MG ยท tablet;oral | Colesevelam Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters